Charles K. Meshul

6.2k total citations
130 papers, 4.9k citations indexed

About

Charles K. Meshul is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Charles K. Meshul has authored 130 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Cellular and Molecular Neuroscience, 59 papers in Neurology and 32 papers in Molecular Biology. Recurrent topics in Charles K. Meshul's work include Neuroscience and Neuropharmacology Research (67 papers), Parkinson's Disease Mechanisms and Treatments (45 papers) and Neurological disorders and treatments (36 papers). Charles K. Meshul is often cited by papers focused on Neuroscience and Neuropharmacology Research (67 papers), Parkinson's Disease Mechanisms and Treatments (45 papers) and Neurological disorders and treatments (36 papers). Charles K. Meshul collaborates with scholars based in United States, Belgium and Türkiye. Charles K. Meshul's co-authors include Cynthia Moore, Charity G. Moore, John C. Morrison, Bruce G. Gold, Cynthia Allen, Madeline J. Churchill, Cindy Moore, Daniel E. Casey, Natalie R.S. Goldberg and Aaron Janowsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Charles K. Meshul

130 papers receiving 4.8k citations

Peers

Countries citing papers authored by Charles K. Meshul

Since Specialization

Citations

This map shows the geographic impact of Charles K. Meshul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles K. Meshul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles K. Meshul more than expected).

Fields of papers citing papers by Charles K. Meshul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles K. Meshul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles K. Meshul. The network helps show where Charles K. Meshul may publish in the future.

Co-authorship network of co-authors of Charles K. Meshul

This figure shows the co-authorship network connecting the top 25 collaborators of Charles K. Meshul. A scholar is included among the top collaborators of Charles K. Meshul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles K. Meshul. Charles K. Meshul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson’s disease 2020 ·European Journal of Neuroscience ·Cindy Moore, (unknown), (unknown), Charles K. Meshul	14
2	Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy 2020 ·Acta Neuropathologica Communications ·Allison J. Schaser, Teresa L. Stackhouse, (unknown), Patrick C. Kerstein, Valerie R. Osterberg, Clàudia López, Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Randall L. Woltjer, Vivek K. Unni	43
3	Glutamate-Glutamine Transfer and Chronic Stress-Induced Sex Differences in Cocaine Responses 2018 ·Neuroscience ·Akiko Shimamoto, (unknown), (unknown), (unknown), Christopher R. Davis, (unknown), (unknown), Cindy Moore, Collin Reynolds, Charles K. Meshul	7
4	The key role of T cells in Parkinson's disease pathogenesis and therapy 2018 ·Parkinsonism & Related Disorders ·(unknown), Dennis Bourdette, Charles K. Meshul, Joseph F. Quinn	30
5	Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson’s disease 2017 ·Brain Research Bulletin ·Eduard Bentea, Cynthia Moore, Lauren Deneyer, Lise Verbruggen, Madeline J. Churchill, Rebecca L. Hood, Charles K. Meshul, Ann Massie	9
6	DENDRITIC SPINES IN THE HIPPOCAMPUS OF GENETIC ABSENCE EPILEPSY RATS (GAERS): AN ULTRASTRUCTURAL OUANTITATIVE ANALYSIS 2016 ·DergiPark (Istanbul University) ·Serap Şirvancı, (unknown), Charles K. Meshul, Filiz Onat, Tangül Şan	1
7	Exercise intervention increases spontaneous locomotion but fails to attenuate dopaminergic system loss in a progressive MPTP model in aged mice 2016 ·Brain Research ·Rebecca L. Hood, William A. Liguore, Cynthia Moore, (unknown), Charles K. Meshul	27
8	An ultrastructural analysis of the effects of ethanol self-administration on the hypothalamic paraventricular nucleus in rhesus macaques 2015 ·Frontiers in Cellular Neuroscience ·(unknown), Christa M. Helms, Anda Cornea, Charles K. Meshul, Kathleen A. Grant	23
9	Presynaptic Alpha-Synuclein Aggregation in a Mouse Model of Parkinson's Disease 2014 ·Journal of Neuroscience ·Kateri J. Spinelli, (unknown), Valerie R. Osterberg, Madeline J. Churchill, (unknown), Cynthia Moore, Charles K. Meshul, Vivek K. Unni	110
10	NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons 2012 ·NeuroToxicology ·Adam C. Munhall, Yan-Na Wu, John K. Belknap, Charles K. Meshul, Steven W. Johnson	7
11	CART Peptide Is a Potential Endogenous Antioxidant and Preferentially Localized in Mitochondria 2012 ·PLoS ONE ·Peizhong Mao, Charles K. Meshul, Philippe Thuillier, Natalie R.S. Goldberg, P. Hemachandra Reddy	46
12	Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 2011 ·Neuroscience ·Natalie R.S. Goldberg, (unknown), Noha Lim, (unknown), Charles K. Meshul	41
13	MK-801 inhibits l-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism 2010 ·Neuropharmacology ·Melanie Paquette, (unknown), (unknown), Charles K. Meshul, Steven W. Johnson, S. Paul Berger	28
14	Down-Regulation of ZnT8 Expression in INS-1 Rat Pancreatic Beta Cells Reduces Insulin Content and Glucose-Inducible Insulin Secretion 2009 ·PLoS ONE ·Yi Fu, Wei Tian, Emily B. Pratt, (unknown), (unknown), Charles K. Meshul, David Cohen	59
15	Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum 2009 ·Neuroreport ·Ruth H. Walker, Rick J. Koch, (unknown), Cynthia Moore, Charles K. Meshul	25
16	Dopamine Modulates Release from Corticostriatal Terminals 2004 ·Journal of Neuroscience ·Nigel S. Bamford, Siobhan Robinson, Richard D. Palmiter, John A. Joyce, Cynthia Moore, Charles K. Meshul	176
17	Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration 2001 ·Psychopharmacology ·Ole A. Andreassen, Charles K. Meshul, Cindy Moore, Hugo A. Jørgensen	25
18	Alterations in Rat Striatal Glutamate Synapses Following a Lesion of the Cortico- and/or Nigrostriatal Pathway 2000 ·Experimental Neurology ·Charles K. Meshul, (unknown), H.W. Cheng, Cynthia Moore, (unknown), Thomas H. McNeill	59
19	Haloperidol-induced morphological changes in striatum are associated with glutamate synapses 1994 ·Brain Research ·Charles K. Meshul, (unknown), Barry Taylor, Aaron Janowsky	114
20	SYNAPTIC VESICLES AND TRANSMITTER RELEASE AT THE NEUROMUSCULAR JUNCTION. 1982 ·Figshare ·Charles K. Meshul	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact